Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature

• Egile Nagusiak: Giuseppe Caruso (Egilea), Annalisa Scopelliti (Egilea), Sara Scaramuzzino (Egilea), Giuseppina Perrone (Egilea), Paola Galoppi (Egilea), Innocenza Palaia (Egilea), Ludovico Muzii (Egilea), Pierluigi Benedetti Panici (Egilea), Roberto Brunelli (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: Peripartum cardiomyopathy (PPCM) is a rare and idiopathic form of dilated cardiomyopathy presenting late in pregnancy or early postpartum. Since the 16-kDa fragment of prolactin has been identified as a key factor in the pathophysiology of PPCM, prolactin inhibitors have been used as a...